Stomach microbe exposure may be linked to more than 1 in 5 bowel cancer cases worldwide

A new study suggests that exposure to the stomach bacterium Helicobacter pylori may be linked to over 20% of colorectal cancer cases worldwide. Researchers emphasize the need for further studies to determine if antibiotic eradication therapy can reduce cancer risk.
Why it matters
Identifying a potential link between a common bacterium and a leading cause of cancer death could significantly impact global preventative health strategies.
edited by Gaby Clark , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: MART PRODUCTION from Pexels Exposure to the stomach microbe Helicobacter pylori may be associated with more than 1 in 5 cases of colorectal cancer worldwide, suggests an exploratory risk-attribution study published in the journal eGastroenterology .
Those born in more recent decades may be at greater risk of the disease after exposure, the analysis suggests, and high-quality long-term studies are needed to determine whether eradication therapy with antibiotics significantly lowers colorectal cancer risk, the researchers conclude.
Colorectal cancer is the second-leading cause of cancer-related death. In 2022, there were nearly 2 million new cases and 900,000 deaths from the disease worldwide, the researchers note.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in